Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xarelto vs. Coumadin for Wound Drainage After Hip or Knee Arthroplasty
NCT02054936Phase 4Withdrawn
- Sponsor
- University of Michigan
- Start
- Mar 2014
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rivaroxaban in venous thromboembolism (VTE), sponsored by University of Michigan. Planned start Mar 2014; status: withdrawn.
02
Drugs
rivaroxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT02054936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02054936.